Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Jiménez · SciRah

Researcher profile · Semantic Scholar

M. Jiménez

Share profile

M. Jiménez — researcher profile on SciRah

h-index: 9
Works: 48
Citations: 308

Most-cited papers

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
L. Goldstein, M. Mansutti, C. Lévy, Jenny C. Chang +49 more
2021Breast Cancer Research and Treatment77 citations Open access
Semantic Scholar
Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana’s predictive model
A. M. Muñoz Martín, P. Alfonso, A. B. Rupérez Blanco, S. Ramírez +2 more
2014Clinical and Translational Oncology57 citations
Semantic Scholar
Clinical guide SEOM on venous thromboembolism in cancer patients
A. M. Muñoz Martín, C. Puig, L. M. Navarro Martín, P. García +1 more
2014Clinical and Translational Oncology19 citations Open access
Semantic Scholar
Clinical guide SEOM on venous thromboembolism in cancer patients
A. M. Martín, C. Puig, L. M. Navarro Martín, P. García +1 more
201419 citations Open access
Semantic Scholar
LBA4 Updated overall survival (OS) results from the first-line (1L) population in the phase III MONALEESA-3 trial of postmenopausal patients (PTS) with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib (RIB) + fulvestrant (FUL)
P. Neven, P. A. Fasching, S. Chia, G. Jerusalem +14 more
2022Annals of Oncology16 citations Open access
Semantic Scholar
Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status
L. O. Morán, P. Alfonso, I. A. Caballero, B. M. García +7 more
2020Clinical and Translational Oncology15 citations
Semantic Scholar
Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies
J. Vázquez, S. Cobo, J. García-Sáenz, A. Herráez +6 more
2006Clinical and Translational Oncology14 citations
Semantic Scholar
Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2.
A. M. Muñoz Martín, P. Alfonso, A. Rupérez, M. Jiménez
2016Oncology Letters11 citations Open access
Semantic Scholar
A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies
G. Curigliano, M. Jiménez, T. Shimizu, B. Keam +14 more
2024ESMO Open9 citations Open access
Semantic Scholar
7P Independent validation of HER2DX ERBB2 mRNA score to predict HER2-positive (HER2+), HER2-low and HER2-0 status in breast cancer
E. S. Torres, G. Villacampa, T. Pascual, M. Oliveira +16 more
2023ESMO Open7 citations Open access
Semantic Scholar
Abstract CT103: Phase I study of LHC165 ± spartalizumab (PDR001) in patients (pts) with advanced solid tumors
G. Curigliano, M. Jiménez, Toshio Shimizu, B. Keam +10 more
2021Clinical Trials7 citations
Semantic Scholar
148OPhase III evaluating the addition of fulvestrant (F) to anastrozol (A) as adjuvant therapy in postmenopausal women with hormone receptor positive HER2 negative (HR+/HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study
M. Ruíz-Borrego, M. Jiménez, A. Ruiz, A. Lluch +15 more
20176 citations Open access
Semantic Scholar
149ONeratinib after trastuzumab (T)-based adjuvant therapy in early-stage HER2+ breast cancer (BC): 5-year analysis of the phase III ExteNET trial
M. Jiménez, F. Holmes, B. Ejlertsen, S. Delaloge +16 more
20175 citations Open access
Semantic Scholar
New clinical trials regulation in Spain: analysis of royal decree 1090/2015
M. Jiménez, A. Ferrandiz, J. A. Urtasun, R. García-Campelo +9 more
2016Clinical and Translational Oncology5 citations Open access
Semantic Scholar
323TiPEarLEE-1: A phase 3 study of ribociclib + endocrine therapy (ET) for adjuvant treatment of patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), high-risk, early breast cancer (EBC)
M. Jiménez, T. Bachelot, C. Barrios, K. Blackwell +13 more
20174 citations Open access
Semantic Scholar
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients
A. C. Mena, Luis Paz-Ares Rodríguez, Á. Lescure, A. C. D. de Tejerina +11 more
20094 citations
Semantic Scholar
273TiP ACE-Breast-03: A phase II study patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimens treated with ARX788
S. Hurvitz, K. Kalinsky, D. Tripathy, G. Sledge +15 more
2022Annals of Oncology3 citations Open access
Semantic Scholar
229MO Overall survival (OS) of palbociclib (P) plus endocrine therapy (ET) versus capecitabine (CAP) in hormone-receptor+/HER2- metastatic breast cancer (MBC) that progressed on aromatase inhibitors (AIs): Final results of the PEARL study
M. Jiménez, C. Zielinski, M. Ruíz-Borrego, E. Carrasco +16 more
2021Annals of Oncology3 citations Open access
Semantic Scholar
162PDPathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification (TNBCtype-4)
I. E. Diaz-Guardamino, A. Picornell, S. López-Tarruella, Y. Jerez +16 more
20173 citations Open access
Semantic Scholar
177PEffects of neratinib (N) on health-related quality of life (HRQoL) in early-stage HER2+ breast cancer (BC): longitudinal analyses from the phase III ExteNET trial
S. Delaloge, Y. Ye, D. Cella, M. Buyse +16 more
20173 citations Open access
Semantic Scholar
Alteraciones gastrointestinales en una paciente con inmunodeficiencia variable común
A. L. Martín, H. Hallal, J. M. Barón, F. Vera +2 more
20023 citations
Semantic Scholar
102P HER2DX risk-score in early-stage HER2-positive (HER2+) breast cancer: A correlative analysis of 757 patients from the Sweden Cancerome Analysis Network - Breast (SCAN-B) dataset
T. Pascual, G. Villacampa, F. Brasó-Maristany, L. P. Brunet +16 more
2023ESMO Open2 citations Open access
Semantic Scholar
93MO Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy for adjuvant HR+, HER2-, node-positive, high-risk, early breast cancer (EBC)
N. Harbeck, V. Guarneri, J. Seo, J. C. Jurado +10 more
2023ESMO Open2 citations Open access
Semantic Scholar
126MO HER2DX and pathological complete response in HER2-positive breast cancer: A combined analysis of 4 neoadjuvant studies
A. Waks, G. Villacampa, L. P. Brunet, N. Tung +16 more
2023ESMO Open2 citations Open access
Semantic Scholar
83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes
M. Jiménez, M. Gnant, B. Ejlertsen, J. Mansi +8 more
20202 citations Open access
Semantic Scholar
23P Clinical, pathological and gene expression features of HER2-low breast cancer
F. Schettini, N. Chic, F. Brasó-Maristany, L. Paré +16 more
20202 citations Open access
Semantic Scholar
LBA20Safety and immunobiological activity of intratumoral (IT) double-stranded RNA (dsRNA) BO-112 in solid malignancies: First in human clinical trial
I. M. Rodas, M. Rodriguez Ruiz, S. Cobo, J. L. Pérez Gracia +15 more
20172 citations Open access
Semantic Scholar
Microangiopathic Hemolytic Anemia and Diffuse Bone Metastasis by Signet Ring Cell Adenocarcinoma
A. M. Muñoz Martín, P. Alfonso, M. del Carmen, Riesco Martínez +3 more
20102 citations Open access
Semantic Scholar
Endocrine therapy of metastatic breast cancer
L. R. Lajusticia, M. Jiménez, S. Cobo
20082 citations
Semantic Scholar
144P Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib (RIB) + fulvestrant (FUL) as first-line (1L) and second-line (2L) therapy in MONALEESA-3 (ML-3)
P. Fasching, P. Neven, G. Jerusalem, J. Beck +11 more
20201 citations Open access
Semantic Scholar
408PValidation of the Royal Marsden Hospital (RMH) prognostic score on an enriched early treatment line cohort for phase I trial patients
M. Codesido, A. Ferrandiz, S. Cobo, R. Álvarez +13 more
20171 citations Open access
Semantic Scholar
186PBreast cancer PAM50 subtypes: Correlation between RNA-Seq and multiplexed gene expression platforms
A. Picornell, I. E. Diaz-Guardamino, E. Alvarez-Castillo, S. Cobo +16 more
20171 citations Open access
Semantic Scholar
Breast cancer in Spain.
M. Jiménez
20061 citations
Semantic Scholar
[Gastrointestinal alterations in a female patient with common variable immunodeficiency].
A. L. Martín, H. Hallal, J. Baron, F. Vera +2 more
2002Gastroenterology & hepatology1 citations
Semantic Scholar
251P Body mass index as a predictive factor for efficacy of taxane-based chemotherapy in early breast cancer patients
J. García-Sáenz, G. Spera, M. Pollán, B. Bermejo +13 more
2023Annals of Oncology0 citations Open access
Semantic Scholar
114P Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies
S. Cobo, M. Pollán, R. Conejero, M. Jiménez +16 more
2023ESMO Open0 citations Open access
Semantic Scholar
62P Outcomes of high-risk breast cancer (BC) patients from El Álamo IV registry and GEICAM adjuvant clinical trials
M. Jiménez, Á. Rodríguez-Lescure, R. A. Conejero, S. S. Tormo +16 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Abstract P4-11-26: The importance of physical exercise in cardiovascular fitness in breast cancer survivors. A cross sectional study: WIM 2.0
Lucía Gil Herrero, Marina Pollán Santamaría, M. Jiménez, S. L. Tarruella +2 more
2022Cancer Research0 citations
Semantic Scholar
Abstract P4-12-01: Adherence with adjuvant endocrine therapy with or without Palbociclib in the PALLAS trial
E. Shinn, D. Zahrieh, A. DeMichele, N. Zdenkowski +37 more
2022Cancer Research0 citations
Semantic Scholar
OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
C. Jiménez, C. Abad, J. L. Catoya Villa, A. G. Ortiz de la Tabla +4 more
2021Thrombosis Research0 citations Open access
Semantic Scholar
PO-58 Venous and arterial tromboembolic events among hospitalized cancer patients with SARS-COV2 infection
C. Abad, J. L. Catoya Villa, A. G. Ortiz de la Tabla, S. Juliao Caamaño +4 more
2021Thrombosis Research0 citations Open access
Semantic Scholar
PO-56 Relationship between clinical presentation of SARS-CoV-2 infection and risk of thromboembolic events and prognosis in cancer patients
J. L. Catoya Villa, A. G. Ortiz de la Tabla, D. S. Juliao Caamaño, C. Jiménez +4 more
2021Thrombosis Research0 citations Open access
Semantic Scholar
143P Quality of life (QoL) with palbociclib (PAL) plus endocrine therapy (ET) versus (vs) capecitabine (CAP) in luminal metastatic breast cancer (MBC) patients (pts) in the PEARL study
Z. Kahan, M. Gil-Gil, M. Ruíz-Borrego, E. Carrasco +16 more
20200 citations Open access
Semantic Scholar
142P Quality-adjusted survival with ribociclib plus fulvestrant (R+F) versus placebo plus fulvestrant (P+F) in postmenopausal women (PMW) HR+/HER2- advanced breast cancer (ABC) based on the MONALEESA-3 trial
G. Jerusalem, T. Delea, M. Jiménez, M. de Laurentiis +9 more
20200 citations Open access
Semantic Scholar
184PDistribution of genomically defined recurrence risk in luminal A and B breast tumors defined by inmunohistochemistry: A retrospective study in Spanish population
S. Ramírez, M. del Monte-Millán, S. López-Tarruella, I. Márquez-Rodas +16 more
20170 citations Open access
Semantic Scholar
1704PDTumor microenvironment biomarkers as therapeutic strategies for TNBC
F. Rojo, M. Borrego, M. Hui, J. M. T. Trigo Perez +14 more
20170 citations Open access
Semantic Scholar
Spanish Society of Medical Oncology (SEOM) Cancer and Thrombosis Working Group.
A. M. Muñoz Martín, V. P. Olmos, M. Jiménez, E. Conejo +1 more
20120 citations Open access
Semantic Scholar
PO56 Prevalence of early menopause/secondary amenorrhea in premenopausal women diagnosed with early breast cancer who received adjuvant or neoadjuvant treatment based on docetaxel
D. L. Ataz, E. Ceballos, S. Cobo, M. Jiménez +3 more
20120 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. M. Muñoz Martín×6
Invite
A. M. Muñoz Martín — researcher profile on SciRah
S. Cobo×6
Invite
S. Cobo — researcher profile on SciRah
J. García-Sáenz×6
Invite
J. García-Sáenz — researcher profile on SciRah
Y. Jerez×5
Invite
Y. Jerez — researcher profile on SciRah

×4

Invite

P. Alfonso — researcher profile on SciRah

A. M. Martín×4

Invite

A. M. Martín — researcher profile on SciRah

M. de Laurentiis×4

Invite

M. de Laurentiis — researcher profile on SciRah

L. O. Morán×4

Invite

L. O. Morán — researcher profile on SciRah

Invite

F. Antón — researcher profile on SciRah

Invite

T. Pascual — researcher profile on SciRah

F. Brasó-Maristany×4

Invite

F. Brasó-Maristany — researcher profile on SciRah

M. Ruíz-Borrego×4

Invite

M. Ruíz-Borrego — researcher profile on SciRah